Cargando…
77P The impact of COVID-19 on gynecological cancer diagnoses in Greece
Autores principales: | Fiste, O., Iliopoulou, P., Tzannis, K., Theofanakis, C., Rouvali, A., Markellos, C., Kunadis, E., Potiri, E., Papanota, A-M., Papatheodoridi, A., Andrikopoulou, A., Svarna, A., Kaparelou, M., Koutsoukos, K., Thomakos, N., Haidopoulos, D., Rodolakis, A., Zagouri, F., Dimopoulos, M., Liontos, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958202/ http://dx.doi.org/10.1016/j.esmoop.2023.100807 |
Ejemplares similares
-
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
por: Liontos, Michalis, et al.
Publicado: (2021) -
BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
por: Liontos, Michalis, et al.
Publicado: (2021) -
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
por: Liontos, M., et al.
Publicado: (2021) -
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023) -
Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
por: Liontos, Michalis, et al.
Publicado: (2021)